507281424	507281424	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
04542098	04542098	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3587452	3587452	CD	B-NP	O
|	|	CC	I-NP	O
7/5/2005	7/5/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
LEFT	LEFT	NNP	I-NP	I-protein
HIP	HIP	NNP	I-NP	I-protein
INFECTION	INFECTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/29/2005	8/29/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/5/2005	4/5/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
FREDERICK	FREDERICK	NNP	B-NP	O
GOLICK	GOLICK	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
hip	hip	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
sustained	sustain	VBD	B-VP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
fall	fall	NN	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
on	on	IN	B-PP	O
11/8/04	11/8/04	CD	B-NP	O
and	and	CC	O	O
suffered	suffer	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
subtrochanteric	subtrochanteric	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
left	left	JJ	B-NP	O
intramedullary	intramedullary	JJ	I-NP	O
nailing	nailing	NN	I-NP	O
at	at	IN	B-PP	O
Rush-j	Rush-j	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hipolito	Hipolito	NNP	I-NP	O
Soderquist	Soderquist	NNP	I-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
weeks	week	NNS	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
drainage	drainage	NN	B-NP	O
noted	note	VBN	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
irrigation	irrigation	NN	I-NP	O
and	and	CC	I-NP	O
debridement	debridement	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
where	where	WRB	B-ADVP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
had	have	VBD	B-VP	O
developed	develop	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Methicillin-resistant	Methicillin-resistant	JJ	B-NP	O
staphylococcus	staphylococcus	NN	I-NP	O
aureus	aureus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Lomorerey	Lomorerey	NNP	I-NP	O
Tonlarg	Tonlarg	NNP	I-NP	O
Hospitals	Hospitals	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
5/29/05	5/29/05	CD	B-NP	O
,	,	,	O	O
another	another	DT	B-NP	O
irrigation	irrigation	NN	I-NP	O
and	and	CC	I-NP	O
debridement	debridement	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Matula	Matula	NNP	I-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
rifampin	rifampin	NN	I-NP	O
were	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
convalesced	convalesce	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

Not	Not	RB	B-NP	O
four	four	CD	I-NP	O
days	day	NNS	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
continued	continue	VBN	B-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
continued	continue	VBN	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
arrived	arrive	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
in	in	IN	B-PP	O
place	place	NN	B-NP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Morbid	Morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Polymyositis	Polymyositis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Fibromyalgia	Fibromyalgia	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GERD	GERD	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Osteoarthritis	Osteoarthritis	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

DuoNeb	DuoNeb	NNP	B-NP	O
q.	q.	NNP	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
wheeze	wheeze	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prozac	Prozac	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Benadryl	Benadryl	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Vicodin	Vicodin	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAM	EXAM	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
stable	stable	JJ	I-NP	O
,	,	,	I-NP	O
serosanguineous	serosanguineous	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
left	left	JJ	B-NP	O
hip	hip	NN	I-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
pain	pain	VB	I-VP	O
.	.	.	O	O

Left	Leave	VBN	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
warm	warm	NN	I-NP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
distributions	distribution	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitting	admit	VBG	I-VP	O
from	from	IN	B-PP	O
clinic	clinic	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
suspected	suspect	VBN	I-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
12	12	CD	I-NP	O
cm	cm	NN	I-NP	O
x	x	SYM	B-NP	O
7	7	CD	B-NP	O
cm	cm	NN	I-NP	O
x	x	SYM	B-NP	O
4.5	4.5	CD	B-NP	O
cm	cm	NN	I-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
lateral	lateral	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
extending	extend	VBG	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
soft	soft	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
contiguity	contiguity	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nail/intramedullary	nail/intramedullary	JJ	I-NP	O
space	space	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
with	with	IN	B-PP	O
general	general	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
including	include	VBG	B-PP	O
desaturations	desaturation	NNS	B-NP	O
and	and	CC	O	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
ventilation	ventilation	NN	B-NP	O
experienced	experience	VBN	B-VP	O
on	on	IN	B-PP	O
irrigation	irrigation	NN	B-NP	O
and	and	CC	I-NP	O
debridement	debridement	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
2004	2004	CD	I-NP	O
management	management	NN	I-NP	O
aims	aim	NNS	I-NP	O
were	be	VBD	B-VP	O
directed	direct	VBN	I-VP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
conservative	conservative	NN	I-NP	O
if	if	IN	B-SBAR	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
possible	possible	JJ	I-NP	O
.	.	.	O	O

YR	YR	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
IR	IR	NN	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
collection	collection	NN	I-NP	O
and	and	CC	I-NP	O
anesthesiology	anesthesiology	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
events	event	NNS	I-NP	O
under	under	IN	B-PP	O
sedation	sedation	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/3/05	3/3/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
CT-guided	CT-guided	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
collection	collection	NN	I-NP	O
with	with	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
drainage	drainage	NN	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
10	10	CD	I-NP	O
cc	cc	NN	I-NP	O
of	of	IN	B-PP	O
pus	pus	NN	B-NP	O
was	be	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
aspirated	aspirate	VBN	I-VP	O
upon	upon	IN	B-PP	O
introduction	introduction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
guiding	guide	VBG	I-NP	O
needle	needle	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
PMNs	PMN	NNS	I-NP	B-cell_type
and	and	CC	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
on	on	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
or	or	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
drawn	draw	VBP	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
with	with	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	B-protein
without	without	IN	B-PP	I-protein
rifampin	rifampin	NN	B-NP	I-protein
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
upon	upon	IN	B-PP	O
previous	previous	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	B-PP	O
despite	despite	IN	B-PP	O
her	her	PRP$	B-NP	O
itchiness	itchiness	NN	I-NP	O
with	with	IN	B-PP	O
infusions	infusion	NNS	B-NP	O
since	since	IN	B-PP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
or	or	CC	I-NP	O
anaphylactic	anaphylactic	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
had	have	VBD	B-VP	O
occurred	occur	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
1000	1000	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
slightly	slightly	RB	B-NP	O
higher	high	JJR	I-NP	O
trough	trough	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
tolerated	tolerate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ID	ID	NNP	I-NP	O
Service	Service	NNP	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
persistence	persistence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
not	not	RB	I-VP	O
recommended	recommend	VBN	I-VP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
continued	continue	VBN	B-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
catheterized	catheterize	VBN	I-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
multistage	multistage	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
hardware	hardware	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
antibiotics	antibiotic	NNS	B-NP	O
spacer	spacer	NN	I-NP	O
placed	place	VBN	B-VP	O
temporarily	temporarily	RB	B-ADVP	O
while	while	IN	B-SBAR	O
longterm	longterm	NN	B-NP	O
IV	IV	CD	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
pursued	pursue	VBN	I-VP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
finally	finally	RB	B-ADVP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
replaced	replace	VBN	B-VP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
arthroplasty	arthroplasty	NN	I-NP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
evidence	evidence	NN	B-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
infection	infection	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
cleared	clear	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/29/05	11/29/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intramedullary	intramedullary	JJ	I-NP	O
nail	nail	NN	I-NP	O
,	,	,	O	O
Girdlestone	Girdlestone	NN	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
beads	bead	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
procedure	procedure	NN	I-NP	O
proceeded	proceed	VBD	B-VP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
including	include	VBG	B-PP	O
any	any	DT	B-NP	O
anesthetic	anesthetic	JJ	I-NP	O
events	event	NNS	I-NP	O
as	as	IN	B-SBAR	O
had	have	VBD	B-VP	O
occurred	occur	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
a	a	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
experiencing	experience	VBG	B-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
rise	rise	NN	I-NP	O
following	follow	VBG	B-PP	O
transfusion	transfusion	NN	B-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	O
stain	stain	NN	I-NP	O
from	from	IN	B-PP	O
intramedullary	intramedullary	JJ	B-NP	O
reamings	reaming	NNS	I-NP	O
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
polys	poly	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
organisms	organism	NNS	I-NP	O
and	and	CC	I-NP	O
cultures	culture	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
described	describe	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
weightbear	weightbear	VB	I-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
preoperative	preoperative	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
stage	stage	NN	I-NP	O
operation	operation	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/23/05	4/23/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
beads	bead	NNS	I-NP	O
and	and	CC	O	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
spacer	spacer	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
see	see	VBP	B-VP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
too	too	RB	I-NP	O
proceeded	proceeded	JJ	I-ADJP	O
without	without	IN	B-PP	O
intraoperative	intraoperative	JJ	B-NP	O
complications	complication	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
postoperatively	postoperatively	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
spacer	spacer	NN	I-NP	O
head	head	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
dislocated	dislocate	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
tolerated	tolerate	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
allowed	allow	VBN	I-VP	O
to	to	TO	I-VP	O
weightbear	weightbear	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
this	this	DT	B-NP	O
minimally	minimally	RB	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
again	again	RB	B-ADVP	O
transfused	transfuse	VBN	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
falling	fall	VBG	B-VP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
shortening	shortening	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
with	with	IN	B-PP	O
external	external	JJ	B-NP	O
rotation	rotation	NN	I-NP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
neurovascular	neurovascular	JJ	B-NP	O
compromise	compromise	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
counseled	counsel	VBN	I-VP	O
that	that	IN	B-SBAR	O
operative	operative	JJ	B-NP	O
exploration	exploration	NN	I-NP	O
and	and	CC	I-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spacer	spacer	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
recommended	recommend	VBN	I-VP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
depressed	depressed	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
prospect	prospect	NN	I-NP	O
of	of	IN	B-PP	O
what	what	WP	B-NP	O
described	describe	VBD	B-VP	O
a	a	DT	O	O
``	``	``	O	O
set	set	VBN	B-VP	O
back	back	RB	B-ADVP	O
.	.	.	O	O
''	''	''	O	O

Psychiatry	Psychiatry	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
support	support	NN	B-NP	O
and	and	CC	I-NP	O
potential	potential	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
deemed	deem	VBD	B-VP	O
fit	fit	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recommend	recommend	VB	I-VP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
current	current	JJ	I-NP	O
antidepressant	antidepressant	NN	I-NP	O
regimen	regimen	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
suggest	suggest	VB	I-VP	O
continued	continued	JJ	B-NP	O
support	support	NN	I-NP	O
by	by	IN	B-PP	O
social	social	JJ	B-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
indeed	indeed	RB	B-ADVP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
10/3/05	10/3/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
peace	peace	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	B-protein
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
space	space	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
fusion	fusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
socket	socket	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
fusion	fusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spacer	spacer	NN	I-NP	O
head	head	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
socket	socket	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
with	with	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
some	some	DT	B-NP	O
difficulty	difficulty	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
shorter	short	JJR	I-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
lift	lift	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
provided	provide	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
voiding	void	VBG	I-VP	O
,	,	,	O	O
tolerating	tolerate	VBG	B-VP	O
regular	regular	JJ	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ambulating	ambulate	VBG	B-VP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
did	do	VBD	B-VP	O
work	work	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
weightbearing	weightbeare	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
with	with	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
precautions	precaution	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
subacute	subacute	JJ	I-NP	O
care	care	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
-LRB-	-LRB-	HYPH	O	O
starting	start	VBG	B-VP	O
date	date	NN	B-NP	O
9/15/05	9/15/05	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Muma	Muma	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
returns	return	VBZ	B-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
service	service	NN	I-NP	O
is	be	VBZ	B-VP	O
reconsulted	reconsulte	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
arrived	arrive	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
wishes	wish	NNS	I-NP	O
and	and	CC	O	O
agreement	agreement	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
7/30/05	7/30/05	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
thereafter	thereafter	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
trough	trough	NN	I-NP	O
level	level	NN	I-NP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
twice	twice	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
shower	shower	VB	I-VP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
,	,	,	O	O
keep	keep	VB	B-VP	O
incision	incision	NN	B-NP	O
clean	clean	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
dry	dry	JJ	I-ADJP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
gauze	gauze	NN	I-NP	O
dressings	dressing	NNS	I-NP	O
,	,	,	O	O
changed	change	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
9/15/05	9/15/05	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
trough	trough	NN	I-NP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
,	,	,	O	O
please	please	VB	B-VP	O
hold	hold	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
adjust	adjust	VB	B-VP	O
and	and	CC	I-VP	O
hold	hold	VB	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
weightbearing	weightbeare	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
lift	lift	NN	I-NP	O
posterior	posterior	JJ	I-NP	O
precautions	precaution	NNS	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gugel	Gugel	NNP	I-NP	O
of	of	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amitriptyline	Amitriptyline	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Valium	Valium	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
muscle	muscle	NN	I-NP	O
spasm	spasm	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Benadryl	Benadryl	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
itching	itch	VBG	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prozac	Prozac	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Nubain	Nubain	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
itching	itch	VBG	B-VP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneus	subcutaneus	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Esomeprazole	Esomeprazole	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

DuoNeb	DuoNeb	IN	B-PP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
wheeze	wheeze	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

premedicated	premedicate	VBN	B-VP	O
with	with	IN	B-PP	O
Benadryl	Benadryl	NN	B-NP	O
for	for	IN	B-PP	O
itching	itch	VBG	B-NP	O
.	.	.	O	O

Tolerate	Tolerate	NNP	B-NP	O
trough	trough	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
hold	hold	NN	I-NP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-0366357	8-0366357	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LANDOLT	LANDOLT	NN	B-NP	O
,	,	,	O	O
ROBIN	ROBIN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TUTSON	TUTSON	NNP	B-NP	O
,	,	,	O	O
ANDERSON	ANDERSON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1335063	1335063	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/30/05	7/30/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/30/05	7/30/05	CD	B-NP	O

